Bluesight Trends Report Reveals Quicker Diversion Investigations and
Bluesight Trends Report Reveals Quicker Diversion Investigations and
New research provides insights into waste events, reduced hospital variances and improved investigations. ALEXANDRIA,…
![](https://bluesight.com/wp-content/uploads/2024/02/3-Ways-to-Establish-and-Measure-an-Effective-Drug-Diversion-Program-Image-150x150.jpg)
3 Ways to Establish and Measure an Effective Drug Diversion Program
A holistic drug diversion program has two things: a strong foundation and key metrics to…
![](https://bluesight.com/wp-content/uploads/2023/02/Blog_Get-to-know-Sandy-Still_v2-150x150.png)
Get to know Sandy Still, PharmD, Bluesight’s newest Director of Clinical Strategy
Sandy Still, PharmD, joins Bluesight as the newest Director of Clinical Strategy. Sandy is a…
![](https://bluesight.com/wp-content/uploads/2022/08/health-2082630_1280-150x150.jpg)
What Does ASHP’s Revised Drug Diversion Guidelines Mean for Your Hospital?
What Does ASHP’s Revised Drug Diversion Guidelines Mean for Your Hospital? By: Sandy Still, PharmD…
![](https://bluesight.com/wp-content/uploads/2022/07/cyber-3400789_1920-150x150.jpg)
Why a Next-Generation Drug Diversion Solution is Vital for Hospitals.
By: Doug Zurawski, Pharm.D. Drug diversion is any act or deviation that removes a…
![](https://bluesight.com/wp-content/uploads/2022/05/Diversion-Trends-Report_2022_Cover_v2-e1654895656953-150x150.png)
The Pandemic’s Continued Strain On Labor And Other Key Takeaways From The Diversion Trends Report
Kit Check recently released its 2022 Diversion Trends Report. In the report, Kit Check analyzed…
![](https://bluesight.com/wp-content/uploads/2021/08/national-cancer-institute-NFvdKIhxYlU-unsplash-150x150.jpg)
5 Signs That You May Need Outside Help with Your Drug Diversion Program
Every hospital today is in some stage of planning, implementing and/or managing a drug diversion…
Diversion Quarterly — Q3 2020
Kit Check is sharing data from its Bluesight™ for Controlled Substances platform on a quarterly…
Doug Zurawski in Pharmacy Times – Enter AI: How Technology is Changing the Pharmaceutical Industry for the Better
Doug Zurawski, Senior Vice President of Clinical Strategy at Kit Check, was recently published in…
Nursing during COVID-19: A Chat with AJ Rivosecchi and Carol Purcell
Kit Check’s Senior Director of Clinical Strategy AJ Rivosecchi sat down (virtually) with Carol Purcell,…